Financials
- Market Capitalization 7.91 M
- Employee 21
- Founded N/A
- CEO N/A
- Website www.aimimmuno.com
- Headquarter Delaware, United States
- FIGI BBG000JL6Z80
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4827 | SKYE Skye Bioscience, Inc. - Common Stock | 1.78 USD | -8.72% | +535.71% | +191.80% | +122.50% | 7.88 M USD | ||
| 4831 | ACXP Acurx Pharmaceuticals, Inc. - Common Stock | 1.45 USD | -0.68% | -1.36% | +3.57% | -24.48% | 7.64 M USD | ||
| 4833 | ENSC Ensysce Biosciences, Inc. - Common Stock | 0.40 USD | 0.00% | +8.11% | +66.67% | +4.58% | 7.78 M USD | ||
| 4834 | CELZ Creative Medical Technology Holdings, Inc. - Common Stock | 1.16 USD | +1.75% | -11.45% | +63.38% | -63.06% | 7.65 M USD |
Frequently asked questions about AIM ImmunoTech Inc.
What is the AIM ImmunoTech Inc. stock price today?
The current price of AIM ImmunoTech Inc. (AIM) is 0.26. Over the past 24 hours, the stock has changed by +4.00%. Follow the AIM chart for real-time price dynamics.
What is the stock ticker of AIM ImmunoTech Inc.?
AIM ImmunoTech Inc. trades under the ticker AIM. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is AIM ImmunoTech Inc. stock going up?
AIM has changed by 0.00% over the last week, +8.33% over the last month, and -89.80% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of AIM ImmunoTech Inc.?
AIM ImmunoTech Inc. currently has a market capitalization of 7.91 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were AIM ImmunoTech Inc. earnings last quarter?
Last quarter, AIM ImmunoTech Inc. reported earnings of -0.43 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was AIM ImmunoTech Inc. revenue for the last quarter?
AIM ImmunoTech Inc. reported quarterly revenue of 26 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was AIM ImmunoTech Inc. net income for the last quarter?
AIM ImmunoTech Inc. reported net income of -3.79 M for the last quarter. The previous quarter showed -3.02 M, which means net income changed by -25.31%.
How many employees does AIM ImmunoTech Inc. have?
As of the latest available data, AIM ImmunoTech Inc. has 21 employees. Workforce size can provide additional context about the company's scale and operations.
What is AIM ImmunoTech Inc. EBITDA?
AIM ImmunoTech Inc. EBITDA is -3.44 M, and its EBITDA margin is -13.21 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy AIM ImmunoTech Inc. stock?
You can buy AIM ImmunoTech Inc. (AIM) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in AIM ImmunoTech Inc. stock?
Investing in AIM ImmunoTech Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AIM chart and related analysis on metatrader.com as part of your research.